| BioID | bio66878 |
| Name | ALPROSTADIL |
| ChEMBL ID | CHEMBL495 |
| Molecular Formula | C20H34O5 |
| Molecular Weight | 354.49 |
| Molecular Weight (Monoisotopic) | 354.2406 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar71 |
| Target Name | None |
| Synonyms | ALPROSTADIL|CAVERJECT|CAVERJECT IMPULSE|EDEX|NSC-165559|ONO-1608|PGE1|PROSTAGLANDIN E1|PROSTIN VR|PROSTIN VR PEDIATRIC|U-10,136|U-10136|VIRIDAL 10|VIRIDAL 20|VIRIDAL 5|VIRIDAL DUO|VITAROS |
| Smiles | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O |
| Inchi | InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1 |
| Inchi Key | GMVPRGQOIOIIMI-DWKJAMRDSA-N |
| Molecular Species | ACID |
| Targets | 158.0 |
| Bioactivities | 1299.0 |
| Np Likeness Score | 1.7 |
| Records Key | ['149 (Prostaglandin E1)', '5 (isomer)', 'SID144204033', '2b (PGE1)', 'A (PGE1)', '4', 'PGE1', 'Alprostadil', 'Prostaglandin E1', 'PGE1', 'PGE1', 'PGE1', 'Alprostadil', 'Alprostadil', 'PGE1', 'Prostaglandin E1', 'PGE1', 'prostaglandin e1', 'PGE-1', '2, PGE1', 'PGE1', 'Prostaglandin E1', 'Alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostoglandin E1 (table SV)', 'Alprostadil', 'Alprostadil', 'ALPROSTADIL', 'PGE1', 'PGE1', 'PGE1', 'PGE1', 'l-PGE1', 'PGE1', 'PGE1', 'Alprostadil', 'Alprostadil', 'Alprostadil脗', 'SID49681576', 'ALPROSTADIL', 'Prostaglandin E1', 'Alprostadil脢', 'ALPROSTADIL', 'alprostadil', 'alprostadil', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'COVC-0673218770', 'ALPROSTADIL', 'SAM001246840', 'alprostadil', 'EUB0000980a', 'EUB0000980a', 'EUB0000980a', 'EUB0000980a', '3; PGE1', 'EUB0000980a', 'alprostadil', 'EUB0000980a', 'BA1000876'] |
| Records Name | ['Prostaglandin E17-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'SID144204033', '7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[(1R,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'Alprostadil', 'Prostaglandin E1', '7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'Alprostadil', '7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', '7-((1R,2R,3R)-3-hydroxy-2-((S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', 'Prostaglandin E1', 'Prostaglandin E1', 'prostaglandin e1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostoglandin E1', 'Prostaglandin E1', 'Alprostadil', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'l-prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Alprostadil', 'Alprostadil', 'Alprostadil脗', 'SID49681576', 'ALPROSTADIL', 'Prostaglandin E1', 'Alprostadil脢', 'ALPROSTADIL', 'alprostadil', 'alprostadil', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'C0164405', 'alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', '7-((1R,2R,3R)-3-hydroxy-2-((S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid', 'Prostaglandin E1', 'alprostadil', 'Prostaglandin E1', 'ALPROSTADIL'] |
| Withdrawn Flag | False |
| Orphan | 0 |